15.36 (-%)
As of Nov 21, 2024
Source:
Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor biology. Our in-house precision medicine platform, SN P, enables rapid and precise drug design through iterative molecular SN Pshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies.
Country | United States |
Headquarters | carlsbad, california |
Phone Number | (619) 728-4760 |
Industry | |
CEO | Todd Harris, Ph.D. |
Website | www.tyra.bio |